Fairvalue-Calculator Fairvalue-Calculator
EN DE

RBC Bioscience Corporation (6848) Fair Value & Analysis

Healthcare · TW · Market cap 273M TWD

Price20.00 TWD
Fair Value14.94 TWD
Upside-25.3%
Quality95/100
Evidence: High Range 14.04 TWD – 23.62 TWD

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

RBC Bioscience Corporation (6848) currently trades at 20.00 TWD, while our model-based Fair Value estimate is 14.94 TWD — implying the stock looks roughly 25.3% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

RBC Bioscience Corporation manufactures and sells reagents and devices for life science and molecular diagnosis Taiwan. It offers MagCore Plus II Automated Nucleic Acid Extractor, a robotic bench-top workstation for nucleic acid purification; MagCore Super Automated Nucleic Acid Extractor, an automated workstation for nucleic acid extraction; and MagCore® EDA Automatic Extraction and Smart PCR Setup, an instrument for nucleic acid extraction and PCR setup pre-treatment. The company also provides NGS, genomic DNA, viral nucleic acids, and total RNA kits. RBC Bioscience Corporation was founded in 1995 and is based in New Taipei City, Taiwan.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -32% Regeneron Pharmaceuticals, Inc (REGN) -4% UCB SA (UCB) -28% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +1% Alnylam Pharmaceuticals, Inc (ALNY) -82%

Frequently asked questions

Is RBC Bioscience Corporation (6848) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 14.94 TWD versus a price of 20.00 TWD — about −25% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 6848?
Our 21-model fair value for RBC Bioscience Corporation is 14.94 TWD (as of Jun 24, 2026), built from audited fundamentals. The current price is 20.00 TWD.
What is the quality score of 6848?
RBC Bioscience Corporation has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.